Chemical Structure : Flumbatinib
CAS No.: 895519-90-1
货号: PC-38393Not For Human Use, Lab Use Only.
Flumatinib (HH-GV678) is a potent BCR-ABL/PDGFR/KIT inhibitor, potently inhibits ABL, PDGFR-β and KIT kinase with IC50 of 1.2, 307.6 and 665.5 nM, respectively.
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
10 mg | ¥880 | In stock | |
25 mg | ¥1480 | In stock | |
50 mg | ¥2480 | In stock | |
100 mg | Get quote |
大包装,大折扣!
E-mail: sales@probechem.com
Tech Support: tech@probechem.com
Flumatinib (HH-GV678) is a potent BCR-ABL/PDGFR/KIT inhibitor, potently inhibits ABL, PDGFR-β and KIT kinase with IC50 of 1.2, 307.6 and 665.5 nM, respectively.
Flumatinib (HH-GV678) displays only weak inhibition of VEGFR2/3, SRC, FLT3, RET, EGFR, and HER2.
Flumatinib (HH-GV678) is a more potent inhibitor of BCR-ABL1 tyrosine kinase than imatinib (IC50=100.9 nM).
Flumatinib (HH-GV678) exhibited a selective inhibition pattern toward imatinib-resistant KIT mutants associated with GISTs, effectively overcame the drug resistance of certain KIT mutants with activation loop mutations (i.e., D820G, N822K, Y823D, and A829P).
Flumatinib (HH-GV678) had superior efficacy compared with imatinib or sunitinib against 32D cells with the secondary mutation Y823D.
分子量 | 562.601 | |
分子式 | C29H29F3N8O | |
外观性状 | Solid | |
储存条件 |
|
|
Solubility |
10 mM in DMSO |
|
Chemical Name/SMILES |
4-(4-Methyl-piperazin-1-ylmethyl)-N-[6-methyl-5-(4-pyridin-3-yl-pyrimidin-2-ylamino)-pyridin-3-yl]-3-trifluoromethyl-benzamide |
1. Luo H, et al. Leukemia. 2010 Oct;24(10):1807-9.
2. Kuang Y, et al. Cancer Chemother Pharmacol. 2020 Sep;86(3):339-346.
3. Zhang L, et al. Clin Cancer Res. 2021 Jan 1;27(1):70-77.
4. Zhao J, et al. Cancer Sci. 2014 Jan;105(1):117-25.
备案号:沪ICP备16042516号-1 Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright